MedTrace Logo

Rechargeable Implantable Vagus Nerve Stimulation System for Drug-Refractory Epilepsy

NCT05993117 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-09-13

No results posted yet for this study

Summary

To evaluate the performance of automatic stimulation mode of a new rechargeable implantable vagus nerve stimulation system for drug-refractory epilepsy

Conditions

  • Drug-Refractory Epilepsy

Interventions

DEVICE

G114R VNS system

All patients treated with Rechargeable Implantable Vagus Nerve Stimulation System (G114R)

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • Beijing Tiantan Hospital

    collaborator OTHER

  • Beijing Pins Medical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Ye Wu · Peking University First Hospital

  • Jianguo Zhang · Beijing Tiantan Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05993117 on ClinicalTrials.gov